The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy

被引：0
|
作者：
Fokas, E. [1 ]
Prevo, R. [1 ]
Reaper, P. [2 ]
Charlton, P. [2 ]
Pollard, J. [2 ]
McKenna, W. G. [1 ]
Muschel, R. [1 ]
Brunner, T. [1 ]
机构：
[1] Univ Oxford, Dept Oncol, Gray Inst Radiat Oncol & Biol, Oxford, England
[2] Vertex Pharmaceut Europe Ltd Abingdon, Oxford, England
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2012年 / 188卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：115 / 116
页数：2
相关论文
共 50 条
  • [31] A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent
    Thakar, Manjusha
    Hu, Yue
    Morreale, Michael
    Lerner, Lane
    Lin, Wan Ying
    Sen, Rupashree
    Cai, Yi
    Karunasena, Enusha
    Thakar, Maya
    Saggi, Soren
    Keer, Harold
    Ahuja, Nita
    PLOS ONE, 2018, 13 (06):
  • [32] ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status
    Huntoon, Catherine J.
    Flatten, Karen S.
    Hendrickson, Andrea E. Wahner
    Huehls, Amelia M.
    Sutor, Shari L.
    Kaufmann, Scott H.
    Karnitz, Larry M.
    CANCER RESEARCH, 2013, 73 (12) : 3683 - 3691
  • [33] Benzyl isothiocyanate sensitizes human pancreatic cancer cells to radiation therapy
    Sahu, Ravi
    Epperly, Michael
    Srivastava, Sanjay
    CANCER RESEARCH, 2009, 69
  • [34] Evaluation of the first potent and highly selective inhibitor of ATR kinase: An approach to selectively sensitize cancer cells to ionizing radiation and hypoxia
    McKenna, Gillies
    Brunner, Thomas
    Charlton, Peter
    Fokas, Emmanouil
    Hammond, Ester
    Mangan, Matthew
    Olcina, Monica
    Pires, Isabel
    Pollard, John
    Prevo, Remko
    Reaper, Philip
    CANCER RESEARCH, 2011, 71
  • [35] Inhibition of Wee1 sensitizes AML cells to ATR inhibitor VE-822-induced DNA damage and apoptosis
    Qi, Wenxiu
    Xu, Xiaohao
    Wang, Manying
    Li, Xiangyan
    Wang, Chaonan
    Sun, Liping
    Zhao, Daqing
    Sun, Liwei
    BIOCHEMICAL PHARMACOLOGY, 2019, 164 : 273 - 282
  • [36] Inhibition of PARP selectively sensitizes KRAS-mutant cancer cells to chemotherapy in vivo - an update
    Haehnel, P. S.
    Sasca, D.
    Enders, B.
    Lehmann, N.
    Roos, W. P.
    Kaina, B.
    Theobald, M.
    Kindler, T.
    Oncology Research and Treatment, 2015, 38 : 98 - 99
  • [37] Benzyl isothiocyanate sensitizes human pancreatic cancer cells to radiation by inducing apoptosis
    Ohara, Maki
    Kimura, Shinichi
    Tanaka, Aya
    Ohnishi, Ken
    Okayasu, Ryuichi
    Kubota, Nobuo
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 (06) : 1043 - 1047
  • [38] Inhibition of βIII-Tubulin Using a Novel Nanoparticle-siRNA Approach Sensitizes Pancreatic Cancer Cells to Chemotherapy
    Teo, J.
    Boyer, C.
    Liu, J.
    Sharbeen, G.
    Erlich, R.
    Youkhana, J.
    Duong, H. T.
    Goldstein, D.
    Davis, T. P.
    Kavallaris, M.
    McCarroll, J.
    Phillips, P. A.
    PANCREAS, 2013, 42 (08) : 1385 - 1385
  • [39] A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy
    Zhang, Di
    Hou, Zhilin
    Aldrich, Kelly E.
    Lockwood, Lizbeth
    Odom, Aaron L.
    Liby, Karen T.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (09) : 1692 - 1701
  • [40] Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents
    Cui, Yuxia
    Palii, Stela S.
    Innes, Cynthia L.
    Paules, Richard S.
    CELL CYCLE, 2014, 13 (22) : 3541 - 3550
12345